Cargando…

Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram

PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huijing, Zhang, Le, Liu, Zhe, Wang, Xiaodong, Geng, Shikai, Li, Jiaoyu, Li, Ting, Ye, Shuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136915/
https://www.ncbi.nlm.nih.gov/pubmed/30237698
http://dx.doi.org/10.2147/PPA.S159293
_version_ 1783355090668617728
author Wang, Huijing
Zhang, Le
Liu, Zhe
Wang, Xiaodong
Geng, Shikai
Li, Jiaoyu
Li, Ting
Ye, Shuang
author_facet Wang, Huijing
Zhang, Le
Liu, Zhe
Wang, Xiaodong
Geng, Shikai
Li, Jiaoyu
Li, Ting
Ye, Shuang
author_sort Wang, Huijing
collection PubMed
description PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were collected from March 2016 to May 2016. Adherence was evaluated using 19-item Compliance Questionnaire Rheumatology. The least absolute shrinkage and selection operator regression model was used to optimize feature selection for the medication nonadherence risk model. Multivariable logistic regression analysis was applied to build a predicting model incorporating the feature selected in the least absolute shrinkage and selection operator regression model. Discrimination, calibration, and clinical usefulness of the predicting model were assessed using the C-index, calibration plot, and decision curve analysis. Internal validation was assessed using the bootstrapping validation. RESULTS: Predictors contained in the prediction nomogram included use of glucocorticoid (GC), use of nonsteroidal anti-inflammatory drugs, number of medicine-related questions, education level, and the distance to hospital. The model displayed good discrimination with a C-index of 0.857 (95% confidence interval: 0.807–0.907) and good calibration. High C-index value of 0.847 could still be reached in the interval validation. Decision curve analysis showed that the nonadherence nomogram was clinically useful when intervention was decided at the nonadherence possibility threshold of 14%. CONCLUSION: This novel nonadherence nomogram incorporating the use of GC, the use of nonsteroidal anti-inflammatory drugs, the number of medicine-related questions, education level, and distance to hospital could be conveniently used to facilitate the individual medication nonadherence risk prediction in IRD patients.
format Online
Article
Text
id pubmed-6136915
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-61369152018-09-20 Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram Wang, Huijing Zhang, Le Liu, Zhe Wang, Xiaodong Geng, Shikai Li, Jiaoyu Li, Ting Ye, Shuang Patient Prefer Adherence Original Research PURPOSE: The aim of this study was to develop and internally validate a medication nonadherence risk nomogram in a Chinese population of patients with inflammatory rheumatic diseases. PATIENTS AND METHODS: We developed a prediction model based on a training dataset of 244 IRD patients, and data were collected from March 2016 to May 2016. Adherence was evaluated using 19-item Compliance Questionnaire Rheumatology. The least absolute shrinkage and selection operator regression model was used to optimize feature selection for the medication nonadherence risk model. Multivariable logistic regression analysis was applied to build a predicting model incorporating the feature selected in the least absolute shrinkage and selection operator regression model. Discrimination, calibration, and clinical usefulness of the predicting model were assessed using the C-index, calibration plot, and decision curve analysis. Internal validation was assessed using the bootstrapping validation. RESULTS: Predictors contained in the prediction nomogram included use of glucocorticoid (GC), use of nonsteroidal anti-inflammatory drugs, number of medicine-related questions, education level, and the distance to hospital. The model displayed good discrimination with a C-index of 0.857 (95% confidence interval: 0.807–0.907) and good calibration. High C-index value of 0.847 could still be reached in the interval validation. Decision curve analysis showed that the nonadherence nomogram was clinically useful when intervention was decided at the nonadherence possibility threshold of 14%. CONCLUSION: This novel nonadherence nomogram incorporating the use of GC, the use of nonsteroidal anti-inflammatory drugs, the number of medicine-related questions, education level, and distance to hospital could be conveniently used to facilitate the individual medication nonadherence risk prediction in IRD patients. Dove Medical Press 2018-09-10 /pmc/articles/PMC6136915/ /pubmed/30237698 http://dx.doi.org/10.2147/PPA.S159293 Text en © 2018 Wang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Wang, Huijing
Zhang, Le
Liu, Zhe
Wang, Xiaodong
Geng, Shikai
Li, Jiaoyu
Li, Ting
Ye, Shuang
Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title_full Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title_fullStr Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title_full_unstemmed Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title_short Predicting medication nonadherence risk in a Chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
title_sort predicting medication nonadherence risk in a chinese inflammatory rheumatic disease population: development and assessment of a new predictive nomogram
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6136915/
https://www.ncbi.nlm.nih.gov/pubmed/30237698
http://dx.doi.org/10.2147/PPA.S159293
work_keys_str_mv AT wanghuijing predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT zhangle predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT liuzhe predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT wangxiaodong predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT gengshikai predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT lijiaoyu predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT liting predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram
AT yeshuang predictingmedicationnonadherenceriskinachineseinflammatoryrheumaticdiseasepopulationdevelopmentandassessmentofanewpredictivenomogram